SCHEMBL9529940

SCHEMBL9529940

CCc1nc(OC)nn1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.41

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 7/20 0.41
AGTR2 P50052 7/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9529441 0.92 AGTR1 (0.46) AGTR1AGTR2
SCHEMBL9530979 0.91 AGTR1 (0.41) AGTR1AGTR2
SCHEMBL9528838 0.90 AGTR1 (0.54) AGTR1AGTR2
SCHEMBL9528343 0.89 AGTR1 (0.51) AGTR1AGTR2
SCHEMBL9527753 0.89 AGTR1 (0.43) AGTR1AGTR2
SCHEMBL9529351 0.89 AGTR1 (0.42) AGTR1AGTR2
SCHEMBL9529760 0.88 AGTR1 (0.41) AGTR1AGTR2
SCHEMBL9528994 0.88 AGTR1 (0.37) AGTR1AGTR2
SCHEMBL9528354 0.88 AGTR1 (0.37) AGTR1AGTR2
SCHEMBL9528999 0.88 AGTR1 (0.37) AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0527851-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1993-02-24 EP disclosed
US-5098920-A Hypotensive agents and treatment of congestive heart failure G. D. SEARLE & CO. (US) 1992-03-24 US disclosed
WO-1991017148-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1991-11-14 WO disclosed